Medical weight management using FDA-approved GLP-1 medications — Wegovy®, Zepbound®, Oral Wegovy®, and Foundayo®. Provider-monitored treatment with both weekly injection and daily pill options to fit your lifestyle.
Oral Wegovy®
Semaglutide 25 mg Tablet
Same active ingredient as injectable Wegovy — semaglutide — but in a once-daily oral tablet. Works by mimicking the GLP-1 hormone to reduce appetite, increase satiety, and support steady weight loss without any needles.
Treatment DetailsFoundayo®
Orforglipron
Foundayo is a non-peptide, oral GLP-1 receptor agonist — meaning it works on the same hunger and metabolism pathways as injectable GLP-1s, but as a simple daily pill with no food or water restrictions required.
Treatment DetailsWegovy®
Semaglutide 2.4 mg
Semaglutide mimics the natural GLP-1 hormone, binding to receptors in the pancreas, stomach, and brain. This leads to increased insulin sensitivity, slowed gastric emptying, appetite suppression, and enhanced satiety.
Treatment DetailsZepbound®
Tirzepatide 2.5–15 mg
Tirzepatide activates both GLP-1 and GIP receptors — a dual mechanism that slows gastric emptying, reduces cravings, and helps the body break down stored fat more efficiently than single-receptor medications.
Treatment Details